Last reviewed · How we verify
Progesterone supplementation
At a glance
| Generic name | Progesterone supplementation |
|---|---|
| Sponsor | Medical University of South Carolina |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Progesterone Preeclampsia (PHASE4)
- Assessment of the Feasibility of Frozen Embryo Transfers in a Natural Cycle Among Obese Compared to Non-Obese Patients
- Assessing the Convenience of Natural Proliferative Phase Frozen Embryo Transfer
- Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer. (PHASE3)
- Rescue Progesterone Supplementation During Frozen Embryo Transfer (PHASE2)
- Estrogen Supplementation and Bone Health in Women With CF (PHASE4)
- Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome (PHASE4)
- Comparison of Two Protocols in Frozen Embryo Transfer (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Progesterone supplementation CI brief — competitive landscape report
- Progesterone supplementation updates RSS · CI watch RSS
- Medical University of South Carolina portfolio CI